These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 9366699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH.
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
    Drehobl M, Guerrero JL, Lacarte PR, Goldstein G, Mata FS, Luber S.
    Curr Med Res Opin; 2008 Dec; 24(12):3531-42. PubMed ID: 19032135
    [Abstract] [Full Text] [Related]

  • 5. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
    Cantrell HF, Lombardy EE, Duncanson FP, Katz E, Barone JS.
    South Med J; 2004 May; 97(5):465-71. PubMed ID: 15180022
    [Abstract] [Full Text] [Related]

  • 6. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A, Rizwan S, Waycaster C, Wall GM.
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [Abstract] [Full Text] [Related]

  • 7. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
    Roland PS, Belcher BP, Bettis R, Makabale RL, Conroy PJ, Wall GM, Dupre S, Potts S, Hogg G, Weber K, Cipro HC Study Group.
    Am J Otolaryngol; 2008 Sep; 29(4):255-61. PubMed ID: 18598837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
    Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW, Ciprodex Otic AOE Study Group.
    Curr Med Res Opin; 2004 Aug; 20(8):1175-83. PubMed ID: 15324520
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
    Klein JO.
    Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
    [Abstract] [Full Text] [Related]

  • 11. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
    Dohar JE, Roland P, Wall GM, McLean C, Stroman DW.
    Curr Med Res Opin; 2009 Feb; 25(2):287-91. PubMed ID: 19192973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media.
    Tong MC, Woo JK, van Hasselt CA.
    J Laryngol Otol; 1996 Apr; 110(4):309-14. PubMed ID: 8733449
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study.
    Supiyaphun P, Tonsakulrungruang K, Chochaipanichnon L, Chongtateong A, Samart Y.
    J Med Assoc Thai; 1995 Jan; 78(1):18-21. PubMed ID: 7622972
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes.
    Dohar JE, Garner ET, Nielsen RW, Biel MA, Seidlin M.
    Arch Otolaryngol Head Neck Surg; 1999 May; 125(5):537-45. PubMed ID: 10326811
    [Abstract] [Full Text] [Related]

  • 18. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea.
    Poetker DM, Lindstrom DR, Patel NJ, Conley SF, Flanary VA, Link TR, Kerschner JE.
    Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1294-8. PubMed ID: 17178938
    [Abstract] [Full Text] [Related]

  • 19. Ofloxacin otic solution: a review of its use in the management of ear infections.
    Simpson KL, Markham A.
    Drugs; 1999 Sep; 58(3):509-31. PubMed ID: 10493278
    [Abstract] [Full Text] [Related]

  • 20. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.
    Arnes E, Dibb WL.
    Curr Med Res Opin; 1993 Sep; 13(3):182-6. PubMed ID: 8222746
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.